Monoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
This study has been completed.
Information provided by (Responsible Party):
National Cancer Institute (NCI)
First received: December 10, 1999
Last updated: February 8, 2013
Last verified: May 2001
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Estimated Study Completion Date:||No date given|
|Primary Completion Date:||June 2005 (Final data collection date for primary outcome measure)|
Link BK, Wang H, Byrd JC, et al.: Phase I trial of humanized 1D10 (Hu1D10) monoclonal anitbody class II molecules in patients with relapsed lymphoma. [Abstract] Proceedings of the American Society of Clinical Oncology 19: A86, 2000.